| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/04/2004 | EP1442741A1 Compositions and methods for treating obesity |
| 08/04/2004 | EP1442143A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/04/2004 | EP1442125A2 Chimeric viral vectors for gene therapy |
| 08/04/2004 | EP1442064A2 Kinases and phosphatases |
| 08/04/2004 | EP1442049A2 Substituted amino ketone compounds |
| 08/04/2004 | EP1442043A1 Condensed pyrimidone derivatives as lp-pla2 inhibitors for the treatment of atherosclerosis |
| 08/04/2004 | EP1442042A1 Polycyclic guanine derivative phosphodiesterase v inhibitors |
| 08/04/2004 | EP1442034A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 08/04/2004 | EP1442025A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 08/04/2004 | EP1442024A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
| 08/04/2004 | EP1442023A1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 08/04/2004 | EP1442020A1 Heterocyclic derivatives of glycinamide and their medical use |
| 08/04/2004 | EP1442019A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/04/2004 | EP1442017A1 Preparation of benzosuberonylpiperidine compounds |
| 08/04/2004 | EP1442008A1 Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 08/04/2004 | EP1441772A2 Polymer conjugates of protein kinase c inhibitors |
| 08/04/2004 | EP1441756A1 Psp-94: use for treatment of hypercalcemia and bone metastasis |
| 08/04/2004 | EP1441752A1 Endophilin homologous proteins involved in the regulation of energy homeostasis |
| 08/04/2004 | EP1441750A2 Linear and cyclic melanocortin receptor-specific peptides |
| 08/04/2004 | EP1441746A1 Composition and method |
| 08/04/2004 | EP1441741A1 Rehydrating formulation |
| 08/04/2004 | EP1441732A2 Thiazole derivative and pharmaceutical use thereof |
| 08/04/2004 | EP1441730A1 Hydrazono-malonitriles |
| 08/04/2004 | EP1441728A2 Modulators of the cholesterol biosynthetic pathway |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441724A1 Methods of increasing endogenous testosterone levels |
| 08/04/2004 | EP1441718A2 Carbinols for the treatment of neuropathic dysfunction |
| 08/04/2004 | EP1441702A2 Method for treating primary insomnia |
| 08/04/2004 | EP1370148A4 Anticholesterolemic edible oil |
| 08/04/2004 | EP1337236B1 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 08/04/2004 | EP1280806B1 THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS |
| 08/04/2004 | EP1278750B1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 08/04/2004 | EP1169054B1 Prognosis of ptp lar related diseases |
| 08/04/2004 | EP1161157B1 Food complement and method for cosmetic treatment based on a grape extract rich in polyphenols |
| 08/04/2004 | EP1157001B1 Oxamic acids and derivatives as thyroid receptor ligands |
| 08/04/2004 | EP1150658B1 Method for controlling liposome size |
| 08/04/2004 | EP1127071B1 Compounds with growth hormone releasing properties |
| 08/04/2004 | EP1077957B1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 08/04/2004 | CN1518559A VHH single heavy chain antibody and method for its preparation in mammal |
| 08/04/2004 | CN1518553A Beta-substituted befa-aminoethyl. phosphonates compound |
| 08/04/2004 | CN1518551A Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient |
| 08/04/2004 | CN1518549A Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/04/2004 | CN1518547A Heterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 08/04/2004 | CN1518546A Selective anthranilamide pyridine amides as inhibitors of VEGRF-2 and VEGFR-3 |
| 08/04/2004 | CN1518543A Pyrazole derivatives and their use as protein kinase inhibitors |
| 08/04/2004 | CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 08/04/2004 | CN1518452A Oral delivery of macromolecules |
| 08/04/2004 | CN1518450A Use of adenosine analogues for treatment of insulin resisttance syndrome and diabetes |
| 08/04/2004 | CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 08/04/2004 | CN1518443A Stable pharmaceutical composition of pravastatin |
| 08/04/2004 | CN1518441A Particles for inhalation having rapid release properties |
| 08/04/2004 | CN1517335A Improved preparation method of Nagelinei |
| 08/04/2004 | CN1517334A Improvement of synthesis process ofhypoglycemic medicine Nagelinei |
| 08/04/2004 | CN1517111A Biological preparation used for freeing stool, weight reducing lowering cholesterol and bllod fat |
| 08/04/2004 | CN1517097A Bambbo leaf flavone freeze dried powser injection, its preparation method and application |
| 08/04/2004 | CN1517093A Sodium glycerophosphate injection and its manufacturing method and application |
| 08/04/2004 | CN1517085A Multi-microelement injecta and its preparation method and application |
| 08/04/2004 | CN1160357C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid |
| 08/04/2004 | CN1160330C N-substituted 2-cyanopyrrolidines compound |
| 08/04/2004 | CN1160130C Plasmid used directly in intramuscular injection for treating diabetes |
| 08/04/2004 | CN1160119C Functions for Tob gene in central nervous system of mammol and its application |
| 08/04/2004 | CN1160113C Medicine and food dual-purpose enriched nutrient for resisting AIDS |
| 08/04/2004 | CN1160107C Weight-lossing hypolipemic medicine |
| 08/04/2004 | CN1160104C Traditional chinese medicine compostion with blood-enrich, tonifying Qi and warming kidney function |
| 08/04/2004 | CN1160094C Health-care product its preparing process |
| 08/04/2004 | CN1160085C New lactic acide fungus preparation having biological purifying activity |
| 08/04/2004 | CN1160076C Pharmaceutical composition comprising bisphosphonic acid |
| 08/04/2004 | CN1160068C Inihibition of lipoprotein oxidation |
| 08/04/2004 | CN1160061C Core tablet for controlled release of gliclazide after oral administration |
| 08/04/2004 | CN1159984C Prophylactic dietary supplement based on milk |
| 08/04/2004 | CN1159974C Summer cypress hypoglycemic tea and its preparing process |
| 08/03/2004 | US6770768 Lowers ldl cholesterol levels in serum and which is fat soluble beta - sitostanol fatty acid ester, and to a method for preparing and using the same. the substance can be taken orally as a food additive, food substitute or supplement. |
| 08/03/2004 | US6770746 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 08/03/2004 | US6770644 Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient |
| 08/03/2004 | US6770643 Inhibit protein kinases |
| 08/03/2004 | US6770626 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors |
| 08/03/2004 | US6770620 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
| 08/03/2004 | US6770307 Plant extract for diabetic therapy |
| 08/03/2004 | US6770296 Hydrophilic core overcoated with hydrophobic hot melt lipid; for water soluble vitamins |
| 08/03/2004 | US6770276 Insulin-containing medicament for peroral application and method for the production thereof |
| 08/03/2004 | US6770133 Stable crystal of thiazolidinedione derivative and process for producing the same |
| 08/03/2004 | CA2322173C Method for producing a fat mixture |
| 08/03/2004 | CA2270386C Process for substituted pyridines |
| 07/31/2004 | CA2417943A1 Weight gain and growth stimulation in mammals by n-acylated glucosamines |
| 07/29/2004 | WO2004063221A1 Metastin derivative and use thereof |
| 07/29/2004 | WO2004063218A1 Obesity-related genes |
| 07/29/2004 | WO2004063202A1 Fused furan compound |
| 07/29/2004 | WO2004063194A1 Heteroaryl compounds |
| 07/29/2004 | WO2004063190A1 Fused heterocyclic derivates as ppar modulators |
| 07/29/2004 | WO2004063184A1 Thiophene derivative ppar modulators |
| 07/29/2004 | WO2004063166A1 Heterocyclic ppar modulators |
| 07/29/2004 | WO2004063165A1 A pyrazole derivative as ppar modulator |
| 07/29/2004 | WO2004063156A1 Novel indole derivates as fabp-4 inhibitors |
| 07/29/2004 | WO2004063155A1 Fused heterocyclic derivatives as ppar modulators |
| 07/29/2004 | WO2004063148A1 Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia |
| 07/29/2004 | WO2004063147A1 Salts and solvates of glucagon antagonists |
| 07/29/2004 | WO2004062672A1 Multivitamin regimen for renal patients |
| 07/29/2004 | WO2004062667A1 Amorphous form of rosiglitazone maleate and process for preparation thereof |
| 07/29/2004 | WO2004062663A1 Use of substituted 2-phenylbenzimidazoles as medicaments |
| 07/29/2004 | WO2004062606A2 Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal |